🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/11/2012 | 41,79 | 41,92 | 41,63 | 41,88 | +0,76% | 0,68% | 7.637.824 |
| 20/11/2012 | 41,43 | 41,67 | 41,26 | 41,56 | +0,51% | 0,99% | 11.428.545 |
| 19/11/2012 | 41,34 | 41,41 | 41,12 | 41,36 | +0,63% | 0,72% | 9.630.806 |
| 16/11/2012 | 40,88 | 41,25 | 40,42 | 41,10 | +0,63% | 2,03% | 17.435.052 |
| 15/11/2012 | 40,99 | 41,16 | 40,60 | 40,84 | -0,58% | 1,37% | 12.872.794 |
| 14/11/2012 | 41,70 | 41,89 | 40,94 | 41,08 | -1,44% | 2,27% | 14.888.831 |
| 13/11/2012 | 41,77 | 42,42 | 41,67 | 41,68 | -0,77% | 1,81% | 10.059.857 |
| 12/11/2012 | 42,43 | 42,48 | 41,87 | 42,00 | -0,07% | 1,44% | 7.681.630 |
| 09/11/2012 | 41,69 | 42,29 | 41,62 | 42,03 | +0,48% | 1,60% | 14.666.970 |
| 08/11/2012 | 42,47 | 42,72 | 41,83 | 41,83 | -1,39% | 2,09% | 17.113.735 |
| 07/11/2012 | 43,46 | 43,58 | 42,16 | 42,42 | -3,18% | 3,27% | 25.223.159 |
| 06/11/2012 | 43,60 | 44,20 | 43,59 | 43,82 | +0,55% | 1,40% | 9.154.594 |
| 05/11/2012 | 43,72 | 43,89 | 43,23 | 43,58 | -0,72% | 1,51% | 9.412.298 |
| 02/11/2012 | 44,13 | 44,42 | 43,88 | 43,89 | +0,13% | 1,21% | 11.580.924 |
| 01/11/2012 | 43,65 | 44,36 | 43,59 | 43,84 | +0,68% | 1,77% | 12.749.968 |
| 31/10/2012 | 44,29 | 44,57 | 43,36 | 43,54 | -1,13% | 2,74% | 14.184.680 |
| 26/10/2012 | 43,69 | 44,63 | 43,69 | 44,04 | -0,32% | 2,14% | 12.513.644 |
| 25/10/2012 | 43,99 | 44,22 | 43,90 | 44,18 | +0,92% | 0,72% | 11.498.132 |
| 24/10/2012 | 43,85 | 44,07 | 43,70 | 43,78 | -0,02% | 0,85% | 10.102.406 |
| 23/10/2012 | 44,07 | 44,40 | 43,77 | 43,79 | -1,27% | 1,43% | 13.104.402 |
| 22/10/2012 | 44,67 | 44,88 | 44,07 | 44,35 | -1,17% | 1,79% | 14.694.427 |
| 19/10/2012 | 45,74 | 45,79 | 44,73 | 44,88 | -1,94% | 2,32% | 13.599.372 |
| 18/10/2012 | 45,12 | 45,80 | 45,11 | 45,76 | +1,20% | 1,52% | 11.513.433 |
| 17/10/2012 | 44,92 | 45,32 | 44,92 | 45,22 | +0,47% | 0,89% | 10.619.279 |
| 16/10/2012 | 44,60 | 45,11 | 44,57 | 45,01 | +1,24% | 1,20% | 12.528.002 |
| 15/10/2012 | 43,65 | 44,49 | 43,60 | 44,46 | +2,13% | 2,06% | 10.774.802 |
| 12/10/2012 | 43,51 | 43,89 | 43,47 | 43,53 | +0,37% | 0,96% | 7.172.826 |
| 11/10/2012 | 43,79 | 43,82 | 43,27 | 43,37 | -0,33% | 1,24% | 7.359.685 |
| 10/10/2012 | 44,06 | 44,27 | 43,32 | 43,51 | -1,23% | 2,14% | 9.930.114 |
| 09/10/2012 | 44,09 | 44,41 | 43,92 | 44,06 | -0,37% | 1,10% | 10.512.383 |